{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:39:26Z","timestamp":1792528766266,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"DOI":"10.1186\/s12969-026-01227-2","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T16:13:59Z","timestamp":1788020039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neurological manifestations and vasculopathy in PLCG2\u2013associated antibody deficiency and immune dysregulation (APLAID): a case series"],"prefix":"10.1186","volume":"24","author":[{"given":"Kosar","family":"Asna Ashari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"MacRae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Hoytema van Konijnenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig D.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Ashoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred P.","family":"See","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Kielian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Danehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riten","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheri","family":"Harder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy A.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankana","family":"Daga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf H.","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia M.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie D.","family":"Ouahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Prockop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esraa","family":"Eloseily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Risma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Ombrello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Dedeoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena M.","family":"Andzelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"issue":"7","key":"1227_CR1","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1007\/s10875-022-01352-z","volume":"42","author":"A Bousfiha","year":"2022","unstructured":"Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, Al-Herz W, et al. The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity. J Clin Immunol. 2022;42(7):1508\u201320.","journal-title":"J Clin Immunol"},{"issue":"5","key":"1227_CR2","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s10875-021-01051-1","volume":"41","author":"C Tsilifis","year":"2021","unstructured":"Tsilifis C, Freeman AF, Gennery AR. STAT3 Hyper-IgE Syndrome-an Update and Unanswered Questions. J Clin Immunol. 2021;41(5):864\u201380.","journal-title":"J Clin Immunol"},{"issue":"25","key":"1227_CR3","first-page":"3154","volume":"127","author":"J Toubiana","year":"2016","unstructured":"Toubiana J, Okada S, Hiller J, Oleastro M, Lagos Gomez M, Aldave Becerra JC, et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood J Am Soc Hematol. 2016;127(25):3154\u201364.","journal-title":"Blood J Am Soc Hematol"},{"issue":"34","key":"1227_CR4","doi-asserted-by":"publisher","first-page":"23083","DOI":"10.1074\/jbc.M109.019265","volume":"284","author":"KL Everett","year":"2009","unstructured":"Everett KL, Bunney TD, Yoon Y, Rodrigues-Lima F, Harris R, Driscoll PC, et al. Characterization of phospholipase C\u03b3 enzymes with gain-of-function mutations. J Biol Chem. 2009;284(34):23083\u201393.","journal-title":"J Biol Chem"},{"key":"1227_CR5","doi-asserted-by":"crossref","unstructured":"Kim YJ, Sekiya F, Poulin B, Bae YS, Rhee SG. Mechanism of B-cell receptor-induced phosphorylation and activation of phospholipase C-\u03b32. Molecular and cellular biology. 2004.","DOI":"10.1128\/MCB.24.22.9986-9999.2004"},{"issue":"12","key":"1227_CR6","doi-asserted-by":"publisher","first-page":"5660","DOI":"10.1073\/pnas.89.12.5660","volume":"89","author":"KM Coggeshall","year":"1992","unstructured":"Coggeshall KM, McHugh JC, Altman A. Predominant expression and activation-induced tyrosine phosphorylation of phospholipase C-gamma 2 in B lymphocytes. Proc Natl Acad Sci. 1992;89(12):5660\u20134.","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"1227_CR7","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.ajhg.2012.08.006","volume":"91","author":"Q Zhou","year":"2012","unstructured":"Zhou Q, Lee G-S, Brady J, Datta S, Katan M, Sheikh A, et al. A hypermorphic missense mutation in PLCG2, encoding phospholipase C\u03b32, causes a dominantly inherited autoinflammatory disease with immunodeficiency. Am J Hum Genet. 2012;91(4):713\u201320.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"1227_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1056\/NEJMoa1102140","volume":"366","author":"MJ Ombrello","year":"2012","unstructured":"Ombrello MJ, Remmers EF, Sun G, Freeman AF, Datta S, Torabi-Parizi P, et al. Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N Engl J Med. 2012;366(4):330\u20138.","journal-title":"N Engl J Med"},{"issue":"11","key":"1227_CR9","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/art.42948","volume":"76","author":"Z Yang","year":"2024","unstructured":"Yang Z, Tao P, Han X, Kozlova A, He T, Volchkov E, et al. Characterization of a Novel Pathogenic PLCG2 Variant Leading to APLAID Syndrome Responsive to a TNF Inhibitor. Arthritis Rheumatol. 2024;76(11):1670\u20138.","journal-title":"Arthritis Rheumatol"},{"key":"1227_CR10","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s10875-020-00794-7","volume":"40","author":"A Mart\u00edn-Nalda","year":"2020","unstructured":"Mart\u00edn-Nalda A, Fortuny C, Rey L, Bunney TD, Alsina L, Esteve-Sol\u00e9 A, et al. Severe autoinflammatory manifestations and antibody deficiency due to novel hypermorphic PLCG2 mutations. J Clin Immunol. 2020;40:987\u20131000.","journal-title":"J Clin Immunol"},{"key":"1227_CR11","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.3389\/fimmu.2018.02863","volume":"9","author":"JF Neves","year":"2018","unstructured":"Neves JF, Doffinger R, Barcena-Morales G, Martins C, Papapietro O, Plagnol V, et al. Novel PLCG2 mutation in a patient with APLAID and cutis laxa. Front Immunol. 2018;9:2863.","journal-title":"Front Immunol"},{"issue":"12","key":"1227_CR12","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1111\/jdv.15918","volume":"33","author":"E Mor\u00e1n-Villase\u00f1or","year":"2019","unstructured":"Mor\u00e1n-Villase\u00f1or E, Saez-de-Ocariz M, Torrelo A, Arostegui JI, Yamazaki-Nakashimada MA, Alc\u00e1ntara-Ortigoza MA, et al. Expanding the clinical features of autoinflammation and phospholipase C\u03b32-associated antibody deficiency and immune dysregulation by description of a novel patient. J Eur Acad Dermatol Venereol. 2019;33(12):2334\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"1227_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jaci.2023.08.036","volume":"153","author":"K Baysac","year":"2024","unstructured":"Baysac K, Sun G, Nakano H, Schmitz EG, Cruz AC, Fisher C, et al. PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variants. J Allergy Clin Immunol. 2024;153(1):230\u201342.","journal-title":"J Allergy Clin Immunol"},{"key":"1227_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.imlet.2020.01.008","volume":"221","author":"A Khabbazi","year":"2020","unstructured":"Khabbazi A, Kafshboran HR, Aghdam MN, Nojadeh JN, Daghagh H, Daneshmandpour Y, et al. A new report of autoinflammation and PLCG2-associated antibody deficiency and immune dysregulation (APLAID) with a homozygous pattern from Iran. Immunol Lett. 2020;221:27\u201332.","journal-title":"Immunol Lett"},{"issue":"1","key":"1227_CR15","doi-asserted-by":"publisher","first-page":"104387","DOI":"10.1016\/j.ejmg.2021.104387","volume":"65","author":"HS Park","year":"2022","unstructured":"Park HS, Oh A, Keum CW, Lee J, Lee JK, Son BR, et al. A novel likely pathogenic PLCG2 variant in a patient with a recurrent skin blistering disease and B-cell lymphopenia. Eur J Med Genet. 2022;65(1):104387.","journal-title":"Eur J Med Genet"},{"issue":"11","key":"1227_CR16","doi-asserted-by":"publisher","first-page":"e319","DOI":"10.1093\/rheumatology\/kead193","volume":"62","author":"T Itakura","year":"2023","unstructured":"Itakura T, Sasaki H, Hosoya T, Yamaguchi T, Mimori E, Saimon Y, et al. A novel gain-of-function missense variant in PLCG2 associated with autoinflammation and hypergammaglobulinaemia. Rheumatology. 2023;62(11):e319\u201321.","journal-title":"Rheumatology"},{"key":"1227_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10875-019-00731-3","volume":"40","author":"T Novice","year":"2020","unstructured":"Novice T, Kariminia A, Del Bel KL, Lu H, Sharma M, Lim CJ, et al. A germline mutation in the C2 domain of PLC\u03b32 associated with gain-of-function expands the phenotype for PLCG2-related diseases. J Clin Immunol. 2020;40:267\u201376.","journal-title":"J Clin Immunol"},{"key":"1227_CR18","doi-asserted-by":"crossref","unstructured":"Wang T, Wang X, Teng Y, Wu L, Zhu F, Ma D, et al. APLAID complicated with arrhythmogenic dilated cardiomyopathy caused by a novel PLCG2 variant. Immunol Res. 2024:1\u20138.","DOI":"10.1007\/s12026-024-09455-y"},{"key":"1227_CR19","doi-asserted-by":"publisher","first-page":"1014150","DOI":"10.3389\/fimmu.2023.1014150","volume":"14","author":"Q Peng","year":"2023","unstructured":"Peng Q, Luo D, Yang Y, Zhu Y, Luo Q, Chen H, et al. Clinical and immunological features of an APLAID patient caused by a novel mutation in PLCG2. Front Immunol. 2023;14:1014150.","journal-title":"Front Immunol"},{"key":"1227_CR20","doi-asserted-by":"publisher","first-page":"667430","DOI":"10.3389\/fimmu.2021.667430","volume":"12","author":"N Wu","year":"2021","unstructured":"Wu N, Zhang B, Wang T, Shen M, Zeng X. Case report: A rare case of autoinflammatory phospholipase C\u03b32 (PLC\u03b32)-associated antibody deficiency and immune dysregulation complicated with gangrenous pyoderma and literature review. Front Immunol. 2021;12:667430.","journal-title":"Front Immunol"},{"issue":"18","key":"1227_CR21","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1093\/emboj\/cdg457","volume":"22","author":"M Nishida","year":"2003","unstructured":"Nishida M, Sugimoto K, Hara Y, Mori E, Morii T, Kurosaki T, et al. Amplification of receptor signalling by Ca2 + entry-mediated translocation and activation of PLCgamma2 in B lymphocytes. Embo j. 2003;22(18):4677\u201388.","journal-title":"Embo j"},{"issue":"7809","key":"1227_CR22","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434\u201343.","journal-title":"Nature"},{"issue":"D1","key":"1227_CR23","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46(D1):D1062\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1227_CR24","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248\u20139.","journal-title":"Nat Methods"},{"issue":"4","key":"1227_CR25","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet. 2016;99(4):877\u201385.","journal-title":"Am J Hum Genet"},{"issue":"D1","key":"1227_CR26","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019;47(D1):D886\u201394.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"1227_CR27","doi-asserted-by":"publisher","first-page":"100905","DOI":"10.1016\/j.jbc.2021.100905","volume":"297","author":"JT Jackson","year":"2021","unstructured":"Jackson JT, Mulazzani E, Nutt SL, Masters SL. The role of PLC\u03b32 in immunological disorders, cancer, and neurodegeneration. J Biol Chem. 2021;297(2):100905.","journal-title":"J Biol Chem"},{"issue":"8","key":"1227_CR28","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1136\/jmedgenet-2017-105216","volume":"55","author":"ME Van Gijn","year":"2018","unstructured":"Van Gijn ME, Ceccherini I, Shinar Y, Carbo EC, Slofstra M, Arostegui JI, et al. New workflow for classification of genetic variants\u2019 pathogenicity applied to hereditary recurrent fevers by the International Study Group for Systemic Autoinflammatory Diseases (INSAID). J Med Genet. 2018;55(8):530\u20137.","journal-title":"J Med Genet"},{"key":"1227_CR29","unstructured":"Deuitch NT, Schwartz DM, Aksentijevich I. Haploinsufficiency of A20. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(\u00ae). Seattle (WA): University of Washington, Seattle. Copyright \u00a9 1993\u20132025, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.; 1993."},{"issue":"2","key":"1227_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/exd.12025","volume":"22","author":"J Uitto","year":"2013","unstructured":"Uitto J, Li Q, Urban Z. The complexity of elastic fibre biogenesis in the skin\u2013a perspective to the clinical heterogeneity of cutis laxa. Exp Dermatol. 2013;22(2):88\u201392.","journal-title":"Exp Dermatol"},{"issue":"6","key":"1227_CR31","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.ejpn.2017.07.003","volume":"21","author":"PF Sinnige","year":"2017","unstructured":"Sinnige PF, van Ravenswaaij-Arts CMA, Caruso P, Lin AE, Boon M, Rahikkala E, et al. Imaging in cutis laxa syndrome caused by a dominant negative ALDH18A1 mutation, with hypotheses for intracranial vascular tortuosity and wide perivascular spaces. Eur J Paediatr Neurol. 2017;21(6):912\u201320.","journal-title":"Eur J Paediatr Neurol"},{"issue":"1","key":"1227_CR32","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s12884-021-03960-w","volume":"21","author":"M Liang","year":"2021","unstructured":"Liang M, Wen H, Li S. Two fetuses in one family of arterial tortuosity syndrome: prenatal ultrasound diagnosis. BMC Pregnancy Childbirth. 2021;21(1):548.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"11","key":"1227_CR33","doi-asserted-by":"publisher","first-page":"390","DOI":"10.31083\/j.fbl2911390","volume":"29","author":"C Zhao","year":"2024","unstructured":"Zhao C, Miao D, Tan D, Shi J, Lv Q, Xiong Z, et al. The PLCG2 Inhibits Tumor Progression and Mediates Angiogenesis by VEGF Signaling Pathway in Clear Cell Renal Cell Carcinoma. Front Biosci (Landmark Ed). 2024;29(11):390.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"1227_CR34","doi-asserted-by":"crossref","unstructured":"Zaidi AH, Yamada JM, Miller DT, McEnaney K, Ireland C, Roberts AE et al. Clinical Syndromic Phenotypes and the Potential Role of Genetics in Pulmonary Vein Stenosis. Child (Basel). 2021;8(2).","DOI":"10.3390\/children8020128"},{"issue":"1","key":"1227_CR35","first-page":"34","volume":"15","author":"SR Quist","year":"2017","unstructured":"Quist SR, Kraas L. Treatment options for pyoderma gangrenosum. JDDG: J der Deutschen Dermatologischen Gesellschaft. 2017;15(1):34\u201340.","journal-title":"JDDG: J der Deutschen Dermatologischen Gesellschaft"},{"issue":"8","key":"1227_CR36","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1055\/a-2245-8457","volume":"124","author":"Z Zhu","year":"2024","unstructured":"Zhu Z, Luo Y, Liao H, Guo R, Hao D, Lu Z, et al. Icaritin Sensitizes Thrombin- and TxA2-Induced Platelet Activation and Promotes Hemostasis via Enhancing PLC\u03b32-PKC Signaling Pathways. Thromb Haemost. 2024;124(8):753\u201369.","journal-title":"Thromb Haemost"},{"issue":"10","key":"1227_CR37","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1182\/blood.2023023659","volume":"144","author":"JA Woyach","year":"2024","unstructured":"Woyach JA, Jones D, Jurczak W, Robak T, Ill\u00e9s \u00c1, Kater AP, et al. Mutational profile in previously treated patients with chronic lymphocytic leukemia progression on acalabrutinib or ibrutinib. Blood. 2024;144(10):1061\u20138.","journal-title":"Blood"},{"issue":"14","key":"1227_CR38","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.7150\/ijbs.98200","volume":"20","author":"X Zhou","year":"2024","unstructured":"Zhou X, Lin J, Shao Y, Zheng H, Yang Y, Li S, et al. Targeting PLCG2 Suppresses Tumor Progression, Orchestrates the Tumor Immune Microenvironment and Potentiates Immune Checkpoint Blockade Therapy for Colorectal Cancer. Int J Biol Sci. 2024;20(14):5548\u201375.","journal-title":"Int J Biol Sci"},{"issue":"11","key":"1227_CR39","doi-asserted-by":"publisher","first-page":"e25008","DOI":"10.1097\/MD.0000000000025008","volume":"100","author":"Z Li","year":"2021","unstructured":"Li Z, Zhao R, Yang W, Li C, Huang J, Wen Z, et al. PLCG2 as a potential indicator of tumor microenvironment remodeling in soft tissue sarcoma. Med (Baltim). 2021;100(11):e25008.","journal-title":"Med (Baltim)"},{"key":"1227_CR40","doi-asserted-by":"publisher","first-page":"3358184","DOI":"10.1155\/2024\/3358184","volume":"2024","author":"B Han","year":"2024","unstructured":"Han B, Xie Q, Liang W, Yin P, Qu X, Hai Y. PLCG2 and IFNAR1: The Potential Biomarkers Mediated by Immune Infiltration and Osteoclast Differentiation of Ankylosing Spondylitis in the Peripheral Blood. Mediators Inflamm. 2024;2024:3358184.","journal-title":"Mediators Inflamm"},{"key":"1227_CR41","doi-asserted-by":"publisher","first-page":"1376288","DOI":"10.3389\/fnins.2024.1376288","volume":"18","author":"Y Lu","year":"2024","unstructured":"Lu Y, Zhang X, Hu L, Cheng Q, Zhang Z, Zhang H, et al. Consistent genes associated with structural changes in clinical Alzheimer\u2019s disease spectrum. Front Neurosci. 2024;18:1376288.","journal-title":"Front Neurosci"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-026-01227-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01227-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01227-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:02:17Z","timestamp":1792526537000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-026-01227-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1227"],"URL":"https:\/\/doi.org\/10.1186\/s12969-026-01227-2","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We have de-identified patient data to the standards of the HIPAA Privacy rule and do not believe the information provided allows the identification of the patients through other means. Based on this, and because this is three or less cases, this does not meet the standards of human subjects\u2019 research in accordance with the IRB standards of Boston Children\u2019s Hospital.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"David Hoytema van Konijnenburg- Consultant for Adivo Associates- Consultant for Guidepoint Global LLC- Funding: DHK was supported by a Child Health Research Career Development Award from the National Institutes of Health - 5K12HD052896. Craig D. Platt- Consultant for Mahzi Therapeutics, Syneos Health. Advisory Board for Sobi, Inc. Royalties from UpToDate. Alfred P. See- Consultant - NeuroBionics, Bionaut, KanekaHospita. Stacy A. Kahn- Fecal Microbiome Transplant National Registry. NIH\/NIAID, NIH 1R24AI118629-01A1. Co-Investigator- Cohort for Pediatric Translational and Clinical Research in IBD (CAPTURE IBD). Crohn's and Colitis Foundation. Co-PI. Jodie D. Ouahed- Consultant for Skygenics. Susan Prockop- Susan Prockop receives support for the conduct of clinical trials through Boston Children\u2019s Hospital from Pierrre Fabre and Cabaletta.- Inventor of IP related to development of third party viral specific T cells program with all rights assigned to Memorial Sloan Kettering Cancer Center. - Consulting Atara Biotherapeutics, Ensoma, HEOM, Pierre Fabre. DSMB Stanford University and NYBC.- Equity share Regatta Biotherapy (a non-excluded organization). Michael J. Ombrello- Funding acknowledgement: Dr. Ombrello is supported by the NIAMS Intramural Research Program (ZIA-AR041198). Milena M. Andzelm - Funding: MMA is supported by the National Institute of Neurological Disorders and Stroke (5K12NS098482) and a Career Development Award from the Boston Children's Hospital Office of Faculty Development. Fatma Dedeoglu- Sobi symposium lecturer and UptoDate royalties for chapter writing.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"76"}}